Logo



 

  (format: symbol-exchange code e.g. IBM-N)

Exchange Codes:  T-Toronto N-New York A-American Q-Nasdaq I-Index
  • Stock Trends Report
  • Charting
  • Industry
  • Profile
  • Social
NYSE FXI
week ending
Friday Aug 16, 2019
   
iShares China Large-Cap ETF
Trend Trend Counters Relative Strength  
(Strong) Bearish Trend. The closing price is below the upper limit of the 13-week MA envelope. This indicates that the short-term bearish trend of the stock's price remains relatively strong. Trading implication: generally considered a negative signal for holding. Trade exit signals already triggered.
Trend / Category
4/ 5
13 week Current wk Unusual Volume
93 +
n/a
  weeks in vs. S&P500  
Trading stats for the Week Stock Trends chart of iShares China Large-Cap ETF $FXI - click for more ST charts
  Close Range
$US 38.60 37.66 - 39.19
1 week %change 13 week %change
-0.4% -5.8%
Average Price
13 week MA 40 week MA
41.02 42.02
52-week range
37.66 - 45.96
Share Volume Relative Volume
196,651,600 139.3%
Total traded value
$7,590,751,760
Traded at 52-week low
Historical ST Data | ST Charts
iShares China Large-Cap ETF (FXI-N)
Trend Rel
Str
+
-
52wk
Hi | Lo
Stock Name
Symbol
Wk Close
Wk
%Chg
Wk
Range
Vol (00's)
Hi/Lo Vol
No Stock Data
Highlighted stocks traded at their 52 week high or low, OR gained/lost more than 10% during the trading week.
Business Description :
The investment seeks to track the investment results of the FTSE China 50 Index composed of large-capitalization Chinese equities that trade on the Hong Kong Stock Exchange. The fund generally invests at least 90% of its assets in securities of the underlying index and in depositary receipts representing securities of the underlying index. The index designed to measure the performance of the largest companies in the Chinese equity market that trade on the Stock Exchange of Hong Kong ("SEHK") and are available to international investors, as determined by FTSE International Limited (the "Index Provider" or "FTSE"). The fund is non-diversified.
Company Website :
  Privacy Policy  |   Terms of Use  |   Syndications  |   Contact Us